Birk Venture is a private equity firm focused on investments in the life science industry. The firm was founded in 2010, in Oslo, Oslo, Norway.
Birk Venture primarily invests in healthcare initiatives like pharmaceuticals, biotechnology, diagnostics, and medical devices or instruments. The businesses and companies that Birk Ventures looks to invest in tend to be either small-sized or start-up companies.
Birk Ventures has made investments in BerGenBio, Nordic Nanovector, APIM Therapeutics, Nextera, Zelluna Immunotherapy, Onco Invent and Targovax.
They have exited their investments in BerGenBio, Targovax, Algeta, Cortendo and PCI Biotech.
Hans Ivar Robinson
CEO and Chairman